Evidence map›Paper›PMID 23786423›Full record

ArticleBMC microbiology2013

Genomic and phenotypic characterization of in vitro-generated Chlamydia trachomatis recombinants.

Brendan M Jeffrey, Robert J Suchland, Steven G Eriksen, Kelsi M Sandoz, Daniel D Rockey

Abstract read
In one paragraph

Article in BMC microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Genome-wide association studies ofInfection and immunity · 2026
    Article
  2. Journal of bacteriology · 2025
    Review
  3. Article
  4. Recognition ofInfection and immunity · 2024
    Article
  5. Metabolic dormancy inInfection and immunity · 2024
    Article
  6. Advances in genetic manipulation ofFrontiers in immunology · 2023
    Review
  7. Article
  8. The Impact of Lateral Gene Transfer inFrontiers in cellular and infection microbiology · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Study on the Occurrence of Genetic Exchange Among Parasites of theFrontiers in cellular and infection microbiology · 2020
    Article
  15. Article
  16. Chromosomal Recombination Targets inJournal of bacteriology · 2019
    Article
  17. Article
  18. Article
  19. The Finnish New Variant ofMicroorganisms · 2019
    Article
  20. Chlamydial Infection From Outside to Inside.Frontiers in microbiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brendan M JeffreyMolecular and Cellular Biology Program, Oregon State University, Corvallis, OR, USA.
Robert J Suchland
Steven G Eriksen
Kelsi M Sandoz
Daniel D Rockey

Funding

Recombination and Genetics in Chlamydia spp.RC1AI086469 · NIAID · OREGON STATE UNIVERSITY · PI ROCKEY, DANIEL D · 2009 to 2010
$993k
Analysis of chlamydial recombination in vivoR21AI088540 · NIAID · OREGON STATE UNIVERSITY · PI ROCKEY, DANIEL D · 2010 to 2011
$400k
NIAID NIH HHS AI086469-01NIAID NIH HHS AI088540-02
6 · The paper itself

Abstract

backgroundPre-genomic and post-genomic studies demonstrate that chlamydiae actively recombine in vitro and in vivo, although the molecular and cellular biology of this process is not well understood. In this study, we determined the genome sequence of twelve Chlamydia trachomatis recombinants that were generated in vitro under antibiotic selection. These strains were used to explore the process of recombination in Chlamydia spp., including analysis of candidate recombination hotspots, and to correlate known C. trachomatis in vitro phenotypes with parental phenotypes and genotypes.

resultsEach of the 190 examined recombination events was the product of homologous recombination, and no candidate targeting motifs were identified at recombination sites. There was a single deletion event in one recombinant progeny that resulted in the removal of 17.1 kilobases between two rRNA operons. There was no evidence for preference for any specific region of the chromosome for recombination, and analyses of a total of over 200 individual recombination events do not provide any support for recombination hotspots in vitro. Two measurable phenotypes were analyzed in these studies. First, the efficiency of attachment to host cells in the absence of centrifugation was examined, and this property segregated to regions of the chromosome that carry the polymorphic membrane protein (Pmp) genes. Second, the formation of secondary inclusions within cells varied among recombinant progeny, but this did not cleanly segregate to specific regions of the chromosome.

conclusionsThese experiments examined the process of recombination in C. trachomatis and identified tools that can be used to associate phenotype with genotype in recombinant progeny. There were no data supporting the hypothesis that particular nucleotide sequences are preferentially used for recombination in vitro. Selected phenotypes can be segregated by analysis of recombination, and this technology may be useful in preliminary analysis of the relationship of genetic variation to phenotypic variation in the chlamydiae.

Indexed as

GenomicsRecombination, GeneticAnti-Bacterial AgentsBacterial ProteinsCell LineChlamydia InfectionsChlamydia trachomatisHumansMolecular Sequence DataPhenotypeAnti-Bacterial AgentsBacterial Proteins

Identifiers

PMID23786423
PMCPMC3703283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.